Search Results - "Vignali, Dario"

Refine Results
  1. 1

    Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups by Andrews, Lawrence P., Yano, Hiroshi, Vignali, Dario A. A.

    Published in Nature immunology (01-11-2019)
    “…Although immunotherapeutics targeting the inhibitory receptors (IRs) CTLA-4, PD-1 or PD-L1 have made substantial clinical progress in cancer, a considerable…”
    Get full text
    Journal Article
  2. 2

    Co-stimulatory and Co-inhibitory Pathways in Autoimmunity by Zhang, Qianxia, Vignali, Dario A.A.

    Published in Immunity (Cambridge, Mass.) (17-05-2016)
    “…The immune system is guided by a series of checks and balances, a major component of which is a large array of co-stimulatory and co-inhibitory pathways that…”
    Get full text
    Journal Article
  3. 3

    Interferon-γ: teammate or opponent in the tumour microenvironment? by Gocher, Angela M., Workman, Creg J., Vignali, Dario A. A.

    Published in Nature reviews. Immunology (01-03-2022)
    “…Cancer immunotherapy offers substantive benefit to patients with various tumour types, in some cases leading to complete tumour clearance. However, many…”
    Get full text
    Journal Article
  4. 4

    IL-12 family cytokines: immunological playmakers by Vignali, Dario A A, Kuchroo, Vijay K

    Published in Nature immunology (01-08-2012)
    “…The interleukin 12 (IL-12) family is unique in having the only heterodimeric cytokines, including IL-12, IL-23, IL-27 and IL-35. This feature endows these…”
    Get full text
    Journal Article
  5. 5

    How regulatory T cells work by Vignali, Dario A. A, Collison, Lauren W, Workman, Creg J

    Published in Nature reviews. Immunology (01-07-2008)
    “…Key Points Regulatory T (T Reg ) cells are essential for maintaining peripheral tolerance, preventing autoimmunity and limiting chronic inflammatory diseases…”
    Get full text
    Journal Article
  6. 6

    T Cell Exhaustion by Baessler, Andrew, Vignali, Dario A.A

    Published in Annual review of immunology (28-06-2024)
    “…T cell responses must be balanced to ensure adequate protection against malignant transformation and an array of pathogens while also limiting damage to…”
    Get full text
    Journal Article
  7. 7

    LAG-3 as the third checkpoint inhibitor by Aggarwal, Vaishali, Workman, Creg J., Vignali, Dario A. A.

    Published in Nature immunology (01-09-2023)
    “…Lymphocyte activation gene 3 (LAG-3) is an inhibitory receptor that is highly expressed by exhausted T cells. LAG-3 is a promising immunotherapeutic target,…”
    Get full text
    Journal Article
  8. 8

    Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer by Cillo, Anthony R., Kürten, Cornelius H.L., Tabib, Tracy, Qi, Zengbiao, Onkar, Sayali, Wang, Ting, Liu, Angen, Duvvuri, Umamaheswar, Kim, Seungwon, Soose, Ryan J., Oesterreich, Steffi, Chen, Wei, Lafyatis, Robert, Bruno, Tullia C., Ferris, Robert L., Vignali, Dario A.A.

    Published in Immunity (Cambridge, Mass.) (14-01-2020)
    “…Head and neck squamous cell carcinoma (HNSCC) arises through exposure to environmental carcinogens or malignant transformation by human papillomavirus (HPV)…”
    Get full text
    Journal Article
  9. 9

    The plasticity and stability of regulatory T cells by Sakaguchi, Shimon, Vignali, Dario A. A., Rudensky, Alexander Y., Niec, Rachel E., Waldmann, Herman

    Published in Nature reviews. Immunology (01-06-2013)
    “…In this Viewpoint article, several experts share their thoughts on the plasticity and stability of regulatory T cells, discussing the recent advances in our…”
    Get full text
    Journal Article
  10. 10

    LAG3 (CD223) as a cancer immunotherapy target by Andrews, Lawrence P., Marciscano, Ariel E., Drake, Charles G., Vignali, Dario A. A.

    Published in Immunological reviews (01-03-2017)
    “…Summary Despite the impressive impact of CTLA4 and PD1‐PDL1‐targeted cancer immunotherapy, a large proportion of patients with many tumor types fail to…”
    Get full text
    Journal Article
  11. 11

    Targeting regulatory T cells in tumors by Liu, Chang, Workman, Creg J., Vignali, Dario A. A.

    Published in The FEBS journal (01-07-2016)
    “…Regulatory T (Treg) cells play a crucial role in maintaining peripheral tolerance and preventing autoimmunity. However, they also represent a major barrier to…”
    Get full text
    Journal Article
  12. 12

    The inhibitory cytokine IL-35 contributes to regulatory T-cell function by COLLISON, Lauren W, WORKMAN, Creg J, KUO, Timothy T, BOYD, Kelli, YAO WANG, VIGNALI, Kate M, CROSS, Richard, SEHY, David, BLUMBERG, Richard S, VIGNALI, Dario A. A

    Published in Nature (22-11-2007)
    “…Regulatory T (T(reg)) cells are a critical sub-population of CD4+ T cells that are essential for maintaining self tolerance and preventing autoimmunity, for…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Type 1 diabetes: translating mechanistic observations into effective clinical outcomes by Herold, Kevan C., Vignali, Dario A. A., Cooke, Anne, Bluestone, Jeffrey A.

    Published in Nature reviews. Immunology (01-04-2013)
    “…Key Points For more than 25 years, type 1 diabetes (T1D) has been recognized as an autoimmune disease. The mechanisms involve innate and adaptive immune…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity by Liu, Chang, Somasundaram, Ashwin, Manne, Sasikanth, Gocher, Angela M., Szymczak-Workman, Andrea L., Vignali, Kate M., Scott, Ellen N., Normolle, Daniel P., John Wherry, E., Lipson, Evan J., Ferris, Robert L., Bruno, Tullia C., Workman, Creg J., Vignali, Dario A. A.

    Published in Nature immunology (01-09-2020)
    “…Robust CD8 + T cell memory is essential for long-term protective immunity but is often compromised in cancer, where T cell exhaustion leads to loss of memory…”
    Get full text
    Journal Article
  18. 18

    Once a Treg, always a Treg? by Sawant, Deepali V., Vignali, Dario A. A.

    Published in Immunological reviews (01-05-2014)
    “…Summary Regulatory T cells (Tregs) prevail as a specialized cell lineage that has a central role in the dominant control of immunological tolerance and…”
    Get full text
    Journal Article
  19. 19

    Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them? by Visperas, Anabelle, Vignali, Dario A A

    Published in The Journal of immunology (1950) (15-11-2016)
    “…Regulatory T cells (Tregs) are critical regulators of peripheral immune tolerance. Treg insufficiency can lead to autoimmune disorders, including type 1…”
    Get full text
    Journal Article
  20. 20

    Interleukin-35 Limits Anti-Tumor Immunity by Turnis, Meghan E., Sawant, Deepali V., Szymczak-Workman, Andrea L., Andrews, Lawrence P., Delgoffe, Greg M., Yano, Hiroshi, Beres, Amy J., Vogel, Peter, Workman, Creg J., Vignali, Dario A.A.

    Published in Immunity (Cambridge, Mass.) (16-02-2016)
    “…Regulatory T (Treg) cells pose a major barrier to effective anti-tumor immunity. Although Treg cell depletion enhances tumor rejection, the ensuing autoimmune…”
    Get full text
    Journal Article